© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
22nd Century Group, Inc. (XXII) stock declined over -1.29%, trading at $3.93 on NASDAQ, down from the previous close of $3.98. The stock opened at $4.07, fluctuating between $3.80 and $4.07 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 20, 2026 | 4.07 | 4.07 | 3.80 | 3.93 | 5.98K |
| Aug 19, 2026 | 4.15 | 4.17 | 3.90 | 3.98 | 15.15K |
| Aug 18, 2026 | 4.21 | 4.28 | 4.07 | 4.07 | 6.54K |
| Aug 17, 2026 | 4.34 | 4.34 | 4.09 | 4.12 | 9.33K |
| Aug 14, 2026 | 3.99 | 4.35 | 3.99 | 4.33 | 9.48K |
| Aug 13, 2026 | 4.33 | 4.33 | 3.73 | 4.11 | 30.31K |
| Aug 12, 2026 | 4.37 | 4.57 | 4.31 | 4.31 | 9.82K |
| Aug 11, 2026 | 4.24 | 4.54 | 4.20 | 4.40 | 4.18K |
| Aug 10, 2026 | 4.29 | 4.50 | 4.23 | 4.35 | 5.47K |
| Aug 07, 2026 | 4.29 | 4.53 | 4.10 | 4.29 | 9.84K |
| Aug 06, 2026 | 4.29 | 4.33 | 4.29 | 4.32 | 1.9K |
| Aug 05, 2026 | 4.40 | 4.49 | 4.04 | 4.36 | 8.41K |
| Aug 04, 2026 | 4.27 | 4.44 | 4.18 | 4.41 | 15.84K |
| Aug 03, 2026 | 4.06 | 4.22 | 4.04 | 4.20 | 5.09K |
| Jul 31, 2026 | 4.05 | 4.05 | 3.90 | 4.00 | 8.58K |
| Jul 30, 2026 | 3.79 | 3.87 | 3.61 | 3.87 | 6.9K |
| Jul 29, 2026 | 3.87 | 3.96 | 3.72 | 3.72 | 10.32K |
| Jul 28, 2026 | 4.07 | 4.07 | 3.90 | 3.93 | 4.85K |
| Jul 27, 2026 | 4.11 | 4.14 | 3.91 | 4.14 | 14.18K |
| Jul 24, 2026 | 4.65 | 4.65 | 4.17 | 4.27 | 8.16K |
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
| Employees | 32 |
| Beta | 0.6 |
| Sales or Revenue | $32.20M |
| 5Y Sales Change% | -0.512% |
| Fiscal Year Ends | December |
| Sector | Consumer Defensive |
| Industry | Tobacco |